22 results
8-K
EX-1.1
MRSN
Mersana Therapeutics Inc
28 Feb 24
Entry into a Material Definitive Agreement
4:08pm
and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act.
(l) Financial Statements. The financial statements
8-K
EX-1.1
g1i2e2ze4bn4cqk yor0
7 Nov 22
Entry into a Material Definitive Agreement
4:05pm
PRE 14A
8qdvhmshhlqg8
18 Apr 22
Preliminary proxy
4:10pm
8-K
EX-1.1
ncw2ob67 t0qxh087i6c
28 Feb 22
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-1.1
dfakem2cw6hjntoin
1 Jun 20
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-1.1
f80vsaaa3dxt3
4 Mar 19
Entry into a Material Definitive Agreement
4:54pm
S-3
EX-1.2
fx2fmr9o7ih
2 Jul 18
Shelf registration
5:27pm